瘤学家的观点和沟通实践关于私人医疗实践中未经证实的高成本癌症干预措施:一个问卷调查调查
Tsunakuni Ikka1,2, Taichi Hatta3, Noriyuki Katsumata4
1Division of Bioethics & Healthcare Law, Institute for Cancer Control, National Cancer Center Japan, Chuo-ku, Japan.
Cancer control : journal of the Moffitt Cancer Center
|October 25, 2025
概括
日本的瘤学家经常收到患者询问未经证实的,昂贵的私人医疗干预措施 (X),尽管他们对这些干预措施进行了负面评价. 需要更清晰的沟通,以确保明智的癌症护理决策.
科学领域:
- 在瘤学瘤学.
- 医学伦理 医学伦理
- 医疗保健服务研究 医疗服务研究
背景情况:
- 日本的公共医疗保险涵盖基于证据的护理.
- 高成本的私人医疗机构,称为"X",提供了缺乏科学证据的先进干预措施.
- 这些干预措施引发了伦理和临床问题,特别是在瘤学中.
研究的目的:
- 探索瘤学家对未经证实的私人医疗干预的看法和反应 (X).
- 为制定针对潜在的剥削行为采取适当对策提供信息.
- 评估瘤学家对X的私人评估与公开沟通之间的差距.
主要方法:
- 一份问卷调查分发给日本医学瘤学会 (n=6273) 的成员.
- 数据是在2024年4月24日至6月10日期间收集的.
- 该调查评估了瘤学家对X的评估,患者的沟通策略和个人偏好.
主要成果:
- 实现了13.2%的响应率 (828个有效响应).
- 63.4%的瘤学家在过去一年中报告了患者对X的询问.
- 76.4%的人对X进行了负面评价,超过90%的人对9项中的7项进行了负面评价,但许多人保持了中立的讨论立场.
- 瘤学家的私人评估和他们与患者的沟通之间存在很大的差距.
- 大多数瘤学家不会为自己选择X,即使没有标准护理选择.
结论:
- 有关未经证实的干预措施 (X) 的透明,基于证据的沟通至关重要.
- 加强对话有助于患者做出明智的决策,维护癌症护理的完整性.
- 医疗专业人员必须提供X的明确评估,以保护患者和公众免受潜在的剥削.
更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
12.1K
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.6K
相关概念视频
Nursing Ethical Principles II
2.1K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.1K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
